Black Diamond Therapeutics (NASDAQ: BDTX)
$2.20
(2.8%)
$0.06
Price as of January 3, 2025, 4:00 p.m. ET
Black Diamond Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Black Diamond Therapeutics Company Info
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
News & Analysis
Featured Article
Why Shares of Black Diamond Therapeutics Skyrocketed This Week
The company announced positive early-trial news for non-small cell lung cancer.
Jim Halley | Jun 29, 2023
Featured Article
How Did Last Week's IPOs Perform?
These four companies just made their debuts. Should they be on your radar?
David Haen | Feb 6, 2020
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.